Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach

Documenti analoghi

• Identification of Iminium Intermediates Generation in the Metabolism of Tepotinib Using LC-MS/MS: In Silico and Practical Approaches to Bioactivation Pathway Elucidation
  di: Abdelhameed, Ali S., et al.
  Pubblicazione: (2020)
• LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay
  di: Attwa, Mohamed W, et al.
  Pubblicazione: (2020)
• Identification and characterization of in vivo, in vitro and reactive metabolites of vandetanib using LC–ESI–MS/MS
  di: Attwa, Mohamed W., et al.
  Pubblicazione: (2018)
• Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies
  di: Attwa, Mohamed W, et al.
  Pubblicazione: (2020)
• Identification of reactive intermediate formation and bioactivation pathways in Abemaciclib metabolism by LC–MS/MS: in vitro metabolic investigation
  di: Adnan A. Kadi, et al.
  Pubblicazione: (2019-01-01)